DENVER, CO, United States, via ETELIGIS INC., 10/27/2014 – – Infinex Ventures, Inc. (OTC Pink: INFX) (PINKSHEETS: INFX), is pleased to announce that it has created a wholly owned subsidiary called Bio Critical Solutions, Inc. that it intends to use to acquire interests in small to mid-sized biotech companies that are focused on the treatment of cancer and critical viral infectious diseases like Ebola. The company will be looking for companies that have promising products that are in various stages of FDA approval that are in need of support. It intends to establish a team of experts to help evaluate these products and for the ones it deems worthy, to find ways to help them to move forward.
"We have heard for years that there are hundreds of cures for the things that ail us, but that the people who have these cures are either being held down or have been quietly squashed. Many of the small companies that we have been approached by, are in fear that they will be taken over and their cures will be nulled out by the big pharmaceutical companies. Our goal is to actively seek out these small companies and try to help them to get their products accepted for use before they get lost in the shuffle and they just give up," said Ron Salem of Infinex Ventures. "This is an extension of our plan to focus on strong candidates in different fields. In this case, we intend to build the strong candidate via acquisitions made into Bio Critical Solutions. In the end, we hope to have built a strong collection of products that tackle many of the bigger medical ailments of the day, along with the teams to help distribute and market them effectively," he added.
About Infinex Ventures
Infinex Ventures, Inc. is a holding company that specializes in putting companies from different industries together to create more value for each. These synergistic relationships can take the form of mergers, acquisitions or even the finding of equity cash infusions or loans. Our team of consultants work in various fields and can provide support to companies in the areas of accounting, manufacturing, distribution, sales, marketing and other areas of general management. We have worked with a diverse array of clients in fields that include mining, food and beverages, hospitality, event and stage planning and the cannabis industries. We have recently expanded our mining interests through our relationship with Advanced Mining Inc., and have created a new medical holding venture called Bio Critical Solutions Inc. www.infxv.com
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "believes," "expects," "may," "will," "intends, "plans," "should," "seeks," "pro forma," "anticipates," "estimates," "continues," or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. A number of factors could cause results to differ materially from those anticipated by such forward-looking statements, including those discussed under "Risk Factors" and "Our Business." Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons.
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE: Infinex Ventures, Inc.